The NovoRapid (insulin apart) Rapid, flexible control brand, founded in 2006 (Denmark), from 307 sister brands and 2214 competing brands. NovoRapid (insulin apart) Rapid, flexible control is owned by NOVO-NORDISK A/S, listed on the stock exchange of Francfort NovoRapid (insulin apart) Rapid, flexible control is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
NOVO-NORDISK A/S
(NovoRapid (insulin apart) Rapid, flexible control)
over 5 years*
EUR 641.20